Cellular Therapy of Cancer with Natural Killer Cells: Will It Ever Work?

This publication has 11 references indexed in Scilit:

• Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
  Nature Immunology, 2000
• Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
  Immunity, 2000
• Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer
  Bone Marrow Transplantation, 2000
• Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
  Blood, 1999
• Induction of sensitivity to NK-mediated cytotoxicity by TNF-α treatment: possible role of ICAM-3 and CD44
  Leukemia, 1998
• During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium
  Nature Medicine, 1996
• Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignancies
  Biotherapy, 1994
• Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction
  New England Journal of Medicine, 1990
• Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells
  New England Journal of Medicine, 1989
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985